Nuclear Medicine: Page 379

Immunomedics revenues sag

By AuntMinnie.com staff writers

Radiopharmaceutical firm Immunomedics reported fiscal fourth-quarter revenues of $900,000, down 47.1% compared with the $1.7 million posted in the fourth quarter of fiscal 2003.

September 8, 2004

Molecular Insight, University of Maryland get NIH grant

By AuntMinnie.com staff writers

Radioisotope imaging developer Molecular Insight Pharmaceuticals of Cambridge, MA, reported that it has received funding from the National Institutes of Health (NIH) to develop molecular imaging pharmaceuticals to detect and noninvasively monitor the activity of angiotensin-converting enzyme (ACE) in patients with congestive heart failure.

August 26, 2004

Neoprobe extends Japanese distribution deal

By AuntMinnie.com staff writers

Gamma probe developer Neoprobe of Dublin, OH, has extended its agreement with its Japanese distributor to include the company's Quantix product line.

August 24, 2004

Molecular Imaging, CCP sign distribution deal

By AuntMinnie.com staff writers

PET imaging services provider Molecular Imaging has entered into a radiopharmaceutical distribution agreement with Custom Care Pharmacy (CCP) of Tampa, FL.

August 23, 2004

Rowers facing more rib stress factures

Rowing has been a competitive sport since it debuted in England in 1716. It became an international collegiate sport in 1793, and men made their Olympic rowing debut in 1900. Despite all that history, there’s not a great deal of medical literature about rowing injuries. But in recent years, rowers are getting hurt in greater numbers, suffering particularly from stress fractures of the ribs.

August 22, 2004

2004 08 11 16 11 37 706

International Isotopes net loss widens

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes reported second-quarter sales of $467,000, down 40.5% compared with the $785,000 booked in the second quarter of 2003.

August 15, 2004

International Isotopes to trade on OTCBB

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes said its company stock will now be trading on the OTC Bulletin Board (OTCBB) under the symbol INIS.

August 15, 2004

Draxis Health books record revenues

By AuntMinnie.com staff writers

Draxis Health reported record second-quarter revenues of $16.7 million, up 42% compared with the $11.8 million turned in during the second quarter of 2003. For the quarter (end-June 30), the Mississauga, Ontario-based vendor had net income of $2.3 million, compared with net income of $700,000 a year ago.

August 11, 2004

Cardiolite finds ischemia in diabetes patients

By AuntMinnie.com staff writers

Pharmaceutical developer Bristol-Myers Squibb Medical Imaging of North Billerica, MA, is touting the results of a clinical study that found that its Cardiolite heart imaging radiopharmaceutical could be effective in detecting coronary artery disease (CAD) in asymptomatic diabetic patients.

August 8, 2004

Palatin receives milestone payment

By AuntMinnie.com staff writers

Contrast agent developer Palatin Technologies said it has received a $2 million milestone payment from its partner Mallinckrodt Imaging, following the recent Food and Drug Administration clearance of Palatin's NeutroSpec agent.

August 5, 2004

Cytogen notches record revenues

By AuntMinnie.com staff writers

Biopharmaceutical firm Cytogen reported record second-quarter revenues of $3.9 million, up 129.4% compared with the $1.7 million turned in a year ago. For the period (end-June 30), the Princeton, NJ-based vendor had a net loss of $4.4 million, compared with a net loss of $3.4 million in the second quarter of 2003.

August 5, 2004

MRI touted for SPECT's role in sizing infarcts

By Tracie L. Thompson

A new report in Radiology is only the second published study of human patients that compares the accuracy of delayed enhancement (DE) MRI versus a nuclear imaging technique for estimating the size of acute infarcts.

August 3, 2004

Page 379 of 439